Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients

Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer

Global trends and inequalities in breast cancer survival and care

Implementation of the Choosing Wisely Africa List in 3 Countries

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy

T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer

ASCO and its Sub-Saharan African outreach programme

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer

SABCS 2023: Highlights

Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients

Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC

Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer